ETrials Worldwide

About:

ETrials Worldwide a Morrisville, NC based provider of software for the clinical trial process.

Website: http://etrials.com/

Top Investors: Prodea, InfoLogix, Newlight Management

Description:

etrials was officially founded in 1999, but has an acquired history that dates back nearly twenty years to the infancy of the eClinical space. The company is privately-financed with corporate headquarters located near Research Triangle Park, North Carolina, and regional sales offices in several locations throughout the U.S. A European base of operations is located in Sittingbourne, Kent in the U.K. etrials provides a comprehensive eClinical solution that spans and supports the entire clinical trial process for the healthcare, pharmaceutical and biotechnology industries. This, coupled with etrials’ unique brand of consulting services, helps guide pharmaceutical companies through the evolution from paper to electronic data processes. The company’s solutions have been used to conduct more than 400 clinical studies in over 50 countries. etrials provides world-class software and services for nearly every aspect of managing, reviewing and comparing information in clinical trials. etrials has developed an open, standards-based technology platform that offers a set of scalable products that fill the needs of small biotechs and large pharma alike. By incorporating cutting edge technology with integrated services, we provide our clients with a systematic approach to running their electronic trials. This means it takes less time to get the trial started, the data is collected faster, and the results are available in real time. More importantly, data integrates with the other processes in the trials, so information is shared throughout the eClinical platform and better decisions can be made in real-time.

Total Funding Amount:

$5M

Headquarters Location:

Morrisville, North Carolina, United States

Founded Date:

1999-01-01

Contact Email:

info(AT)etrials.com

Founders:

Number of Employees:

51-100

Last Funding Date:

2004-01-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai